On the one hand, ERK3 has been shown to promote cancer cell growth and migration in culture conditions and tumor growth and metastasis in xenograft mouse models of different human cancers, including lung cancer [3, 4, 5, 6], head and neck cancer [7], and breast cancer [8, 9, 10]. This evidence concerns the gene MAPK6 and lung cancer.